Literature DB >> 25865441

Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease.

Daniel Alcolea1, Eduard Vilaplana1, Jordi Pegueroles1, Victor Montal1, Pascual Sánchez-Juan2, Andrea González-Suárez2, Ana Pozueta2, Eloy Rodríguez-Rodríguez2, David Bartrés-Faz3, Dídac Vidal-Piñeiro3, Sofía González-Ortiz4, Santiago Medrano4, María Carmona-Iragui1, MaBelén Sánchez-Saudinós1, Isabel Sala1, Sofía Anton-Aguirre1, Frederic Sampedro5, Estrella Morenas-Rodríguez1, Jordi Clarimón1, Rafael Blesa1, Alberto Lleó1, Juan Fortea6.   

Abstract

Cerebrospinal fluid YKL-40 has been described as a marker of glial inflammation. We aimed to study the relationship between YKL-40 and brain structure and its interactions with core Alzheimer's disease (AD) biomarkers. We measured cortical thickness (CTh) and cerebrospinal fluid biomarkers (amyloid-β 1-42 [Aβ42], total tau, p-tau, and YKL-40) of 80 cognitively normal controls and 27 patients with amnestic mild cognitive impairment. Subjects were classified as Aβ42+ (<550 pg/mL) or Aβ42- (>550 pg/mL). CTh difference maps were derived from the interaction and correlation analyses in the whole sample and within clinical groups. There was a strong correlation between YKL-40 and markers of neurodegeneration (total tau and p-tau). In the whole sample, we found a negative correlation between YKL-40 and CTh in AD vulnerable areas in Aβ42+ subjects but not in Aβ42 participants. Our results suggest that YKL-40 could track the inflammatory processes associated to tau-related neurodegeneration in the presence of the AD pathophysiological process.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CSF biomarkers; Cortical thickness; Neuroinflammation; Preclinical Alzheimer's disease; Structural MRI; YKL-40

Mesh:

Substances:

Year:  2015        PMID: 25865441     DOI: 10.1016/j.neurobiolaging.2015.03.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  37 in total

1.  Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.

Authors:  Annie M Racine; Alexandra Touroutoglou; Tatiana Abrantes; Bonnie Wong; Tamara G Fong; Michele Cavallari; Thomas G Travison; Yun Gou; Edward R Marcantonio; David C Alsop; Richard N Jones; Sharon K Inouye; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 2.  Neuroinflammation in Alzheimer's disease: Pleiotropic roles for cytokines and neuronal pentraxins.

Authors:  Ashley Swanson; Tovah Wolf; Alli Sitzmann; Auriel A Willette
Journal:  Behav Brain Res       Date:  2018-02-17       Impact factor: 3.332

3.  The association between tau PET and retrospective cortical thinning in clinically normal elderly.

Authors:  Molly R LaPoint; Jasmeer P Chhatwal; Jorge Sepulcre; Keith A Johnson; Reisa A Sperling; Aaron P Schultz
Journal:  Neuroimage       Date:  2017-05-22       Impact factor: 6.556

4.  A sex-stratified analysis of neuroimmune gene expression signatures in Alzheimer's disease brains.

Authors:  Cristina Sanfilippo; Paola Castrogiovanni; Manlio Vinciguerra; Rosa Imbesi; Martina Ulivieri; Francesco Fazio; Kaj Blennow; Henrik Zetterberg; Michelino Di Rosa
Journal:  Geroscience       Date:  2022-09-22       Impact factor: 7.581

5.  Potential role of chitinase-3-like protein 1 (CHI3L1/YKL-40) in neurodegeneration and Alzheimer's disease.

Authors:  Kevin Connolly; Mikael Lehoux; Ryan O'Rourke; Benedetta Assetta; Guzide Ayse Erdemir; Jack A Elias; Chun Geun Lee; Yu-Wen Alvin Huang
Journal:  Alzheimers Dement       Date:  2022-03-02       Impact factor: 16.655

6.  Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD.

Authors:  Daniel Alcolea; David J Irwin; Ignacio Illán-Gala; Laia Muñoz; Jordi Clarimón; Corey T McMillan; Juan Fortea; Rafael Blesa; Edward B Lee; John Q Trojanowski; Murray Grossman; Alberto Lleó
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-10-08       Impact factor: 10.154

7.  Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.

Authors:  Kelsey E Melah; Sharon Yuan-Fu Lu; Siobhan M Hoscheidt; Andrew L Alexander; Nagesh Adluru; Daniel J Destiche; Cynthia M Carlsson; Henrik Zetterberg; Kaj Blennow; Ozioma C Okonkwo; Carey E Gleason; N Maritza Dowling; Lisa C Bratzke; Howard A Rowley; Mark A Sager; Sanjay Asthana; Sterling C Johnson; Barbara B Bendlin
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

8.  Cerebral amyloid-β load is associated with neurodegeneration and gliosis: Mediation by p-tau and interactions with risk factors early in the Alzheimer's continuum.

Authors:  Gemma Salvadó; Marta Milà-Alomà; Mahnaz Shekari; Carolina Minguillon; Karine Fauria; Aida Niñerola-Baizán; Andrés Perissinotti; Gwendlyn Kollmorgen; Christopher Buckley; Gill Farrar; Henrik Zetterberg; Kaj Blennow; Marc Suárez-Calvet; José Luis Molinuevo; Juan Domingo Gispert
Journal:  Alzheimers Dement       Date:  2021-03-04       Impact factor: 21.566

9.  Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer's Disease and Inflammation at the Pre- and Early Stages of Dementia.

Authors:  Unnur D Teitsdottir; Skarphedinn Halldorsson; Ottar Rolfsson; Sigrun H Lund; Maria K Jonsdottir; Jon Snaedal; Petur H Petersen
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.

Authors:  Michael Schöll; Stephen F Carter; Eric Westman; Elena Rodriguez-Vieitez; Ove Almkvist; Steinunn Thordardottir; Anders Wall; Caroline Graff; Bengt Långström; Agneta Nordberg
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.